X

Vous n'êtes pas connecté

Articles similaires

Alive and Kicking: Watch this space on controversy-free stem-cell therapy trials, says Cynata

stockhead.com.au - 05/Sep 02:35

Stem-cell therapy Cynata Therapeutics (ASX:CYP) outlines a bulging clinical program. PTX and PEB also in the biotech news this morning. ...

Researchers discover blood stem cell could transform bone marrow transplants

hindustantimes.com - 03/Sep 04:52

The study has successfully surmounted a significant obstacle in the production of human blood stem cells.

Sorry! Image not available at this time

Proclinical Staffing: Quality Control Supervisor: Cell Therapy

pharmiweb.com - 06/Sep 09:09

USD125000.00 - USD130000.00 per annum: Proclinical Staffing: Proclinical is seeking a dedicated and experienced Supervisor specializing in Cell...

New discovery offers hope for overcoming CAR-T cell therapy resistance

news.medical.net - 12/Sep 19:17

Mayo Clinic researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in...

Sorry! Image not available at this time

Bombshell Report: Behind-the-Scenes of JFK Jr. & Carolyn Bessette’s Secret Wedding – The Lost Tapes Unveiled | Full HD Documentary

amg-news.com - 10/Sep 18:41

Bombshell Report: Behind-the-Scenes of JFK Jr. & Carolyn Bessette’s Secret Wedding – The Lost Tapes Unveiled | Full HD Documentary Ready to...

Sorry! Image not available at this time

How Do Christians Worship With Spirit and Truth?

christianpublishinghouse.co - 17:00

Discover how Christians embrace worship that aligns with spirit and truth. Explore key practices that deepen their connection to the divine.

CAR T-Cell Therapy: FDA Warning on Secondary Cancer Risks

medindia.net - 11:03

Highlights: Secondary Primary Malignancy rates did not significantly differ among various CAR T-cell therapies or c

CAR T-Cell Therapy: FDA Warning on Secondary Cancer Risks

medindia.net - 11:03

Highlights: Secondary Primary Malignancy rates did not significantly differ among various CAR T-cell therapies or c

Sorry! Image not available at this time

2007 to 2023 Saw Decline in Menopausal Hormone Therapy Usage Rates

drugs.com - 10/Sep 22:33

TUESDAY, Sept. 10, 2024 -- Menopausal hormone therapy (HT) usage rates declined from 2007 to 2023 and remain low, according to a study presented at...

Sorry! Image not available at this time

Labcorp Stock Gains From Market Expansion Efforts Amid Macro Woes

zacks.com - 12/Sep 14:59

LH is well-placed for long-term success in Cell & Gene Therapy, expanding into the consumer market and international growth through the specialty...

Les derniers communiqués

  • Aucun élément